Post-marketing surveillance of administration of botulinum toxin type B(NerBloc)-investigation of the clinical condition in patients with changing from botulinum toxin type A
Not Applicable
- Conditions
- cervical dystonia
- Registration Number
- JPRN-jRCT1080222128
- Lead Sponsor
- Eisai Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Patient with cervical dystonia who was treated by botulinum toxin type A in the past.
Patient who was enrolled in Study NB01S and was evaluated by Toronto Western Spasmodic Torticollis Scale (TWSTRS) at the first injection of NerBloc.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method